A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02538965 · COMPLETED

Trial details

NCT number: NCT02538965
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid

Start date: 2015-11-19
Primary completion: 2017-07-22
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.